# Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection

> **NCT02102152** · NA · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa

## Interventions

- **DRUG:** Tobramycin

## Key facts

- **NCT ID:** NCT02102152
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02102152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02102152, "Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02102152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*